The comparison of the podocyte expression of synaptopodin, CR1 and neprilysin in human glomerulonephritis: Could the expression of CR1 be clinically relevant?

International Journal of Biomedical Science

Volumn 5, Issue 1, 2009, Pages 28-36

  Kubiak Wlekły, Anna ^a   Perkowska Ptasińska, Agnieszka ^b   Olejniczak, Paweł ^a   Rochowiak, Aleksandra ^a   Kaczmarek, Elzbieta ^a   Durlik, Magdalena ^b   Czekalski, Stanisław ^a   Niemer, Zofia I ^a,c  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c NONE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; CREATININE; IMMUNOGLOBULIN A; MEMBRANE METALLOENDOPEPTIDASE; PROTEIN; SYNAPTOPODIN;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; PODOCYTE; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN EXPRESSION; PROTEIN URINE LEVEL;

EID: 70350308321     PISSN: 15509702     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Smoyer W, Mundel P. Regulation of podocyte structure during the development of nephrotic syndrome. J Mol Med. 1998; 76: 172-183.
2. Barisoni L, Kriz W, Mundel P, D'Agati V. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol. 1999; 10: 51-61.
3. Kemeny E, Durmuller U, Nickeleit V, Gudat F, Mihatsch MJ. Distribution of podocyte protein (44 kD) in different types of glomerular diseases. Virchows Arch. 1997; 43: 425-430.
4. Mundel P, Heid HW, Mundel TM et al. Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes. J Cell Biol. 1997; 139: 193-204.
5. Nangaku M, Johnson RJ, Couser WG. Glomerulonephritis and complement regulatory proteins. Exp Nephrol. 1997; 5: 345-354.
6. Moll S, Miot S, Sadallah S et al. No complement receptor 1 stumps on podocytes in human glomerulopathies. Kidney Int. 2001; 59: 160-168.
7. Kazatchkine MD, Fearon DT, Appay MD, Mandet C, Bariety J. Loss of C3b receptor antigen in focal hyalinosis and in proliferative nephritis of systemic lupus erythematosus. J Clin Invest. 1982; 69: 900-912.
8. LeBien TW, McCormack RT. The common acute lymphoblastic leukemia antigen (CD10) - Emancipation from a functional enigma. Blood. 1989; 73: 625-635.
9. Debiec H, Guigonis V, Mougenot B et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med. 2002; 346: 2053-2060.
10. Hara M, Yanagihara T, Itoh M, Matsuno M, Kihara I. Immunohistochemical and urinary markers of podocyte injury. Pediatr Nephrol. 1998; 12: 43-48.
11. Niemir ZI, Stein H, Dworacki G, et al. Podocytes are the major source of IL-1α and IL-1β in human glomerulonephritides. Kidney Int. 1997; 52: 393-403.
12. Niemir ZI, Stein H, Ciechanowicz A et al. The in situ expression of interleukin-8 in the normal human kidney and in different morphological forms of glomerulonephritis. Am J Kidney Dis. 2004; 43: 983-998.
13. Sasaoka A, Nishiya K, Hosokawa T et al. The number of CD10-positive glomerular cells reflects renal prognosis in IgA nephropathy patients. Clin Nephrol. 2003; 60: 305-314.
14. Iida K, Koyama A, Nakamura H et al. Abnormal expression of complement receptor (CR1) in IgA nephritis: increase in erythrocytes and loss on glomeruli in patients with impared renal function. Clin Immunol Immunopathol. 1986; 40: 393-400.
15. Arora M, Arora R, Tiwari SC, Das N, Srivastava LM. Expression of complement regulatory proteins in diffuse proliferative glomerulonephritis. Lupus. 2000; 9: 127-131.
16. Emancipator SN, Iida K, Nussenzweig V, Gallo G.R. Monoclonal antibodies to human complement receptor (CR1) detect defects in glomerular diseases. Clin Immunol Immunopathol. 1983; 27: 170-175.
17. Srivastava T, Garola RE, Whiting JM, Alon US. Synaptopodin expression in idiopathic nephrotic syndrome of childhood. Kidney Int. 2001; 59: 118-125.
18. Hirakawa M, Tsuruya K, Yotsueda H et al. Expression of synaptopodin and GLEPP1 as markers of steroid responsiveness in primary focal segmental glomerulosclerosis. Life Sci. 2006; 79: 757-763.
19. Kaczmarek E, Strzelczyk R. From two to three-dimensional visualization of structures in light and confocal microscopy - applications for biomedical studies. In: Mendez Vilas A, Labajos-Broncano L (eds.): Current Issues on Multidisciplinary Microscopy Research and Education. Badajoz, Formatex. 2005; 289-295.
20. Levey AS, Gassmann JJ, Hall PM, Walker WG. Assessing the progression of renal disease in clinical studies: effects of duration of followup and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. J Am Soc Nephrol. 1991, 1: 1087-1094.
21. Nolasco FE, Cameron JS, Hartley B et al. Abnormal podocyte CR-1 expression in glomerular diseases: association with glomerular cell proliferation and monocyte infiltration. Nephrol Dial Transplant. 1987; 2: 304-312.
22. Colasanti G, Moran J, Bellini A, D'Amico G. Significance of glomerular C3b receptors in human renal diseases. Ren Physiol. 1980; 3: 387- 394.
23. Couser WG. Membranous nephropathy: a long road but well travelled. J Am Soc Nephrol. 2005; 16: 1184-1187.
24. Nangaku M. Complement regulatory proteins in glomerular diseases. Kidney Int. 1998; 54: 1419-1428.